Cost-effectiveness of HPV vaccination in the Netherlands

Even under favorable assumptions, including lifelong protection against 70% of all cervical cancers and no side effects, vaccination against the human papillomavirus (HPV) is not cost-effective in the Netherlands, according to a study published online July 1 in the Journal of the National Cancer Institute.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news165687075.html">Cost-effectiveness of HPV vaccination in the Netherlands</a></p> <p>Even under favorable assumptions, including lifelong protection against 70% of all cervical cancers and no side effects, vaccination against the human papillomavirus (HPV) is not cost-effective in the Netherlands, according to a study published online July 1 in the <i>Journal of the National Cancer Institute</i>.</p>